BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8874207)

  • 1. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy.
    Batova A; Diccianni MB; Nobori T; Vu T; Yu J; Bridgeman L; Yu AL
    Blood; 1996 Oct; 88(8):3083-90. PubMed ID: 8874207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells.
    Efferth T; Miyachi H; Drexler HG; Gebhart E
    Blood Cells Mol Dis; 2002; 28(1):47-56. PubMed ID: 11987241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
    Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
    Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
    Yu J; Batova A; Shao L; Carrera CJ; Yu AL
    Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).
    Harasawa H; Yamada Y; Kudoh M; Sugahara K; Soda H; Hirakata Y; Sasaki H; Ikeda S; Matsuo T; Tomonaga M; Nobori T; Kamihira S
    Leukemia; 2002 Sep; 16(9):1799-807. PubMed ID: 12200696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
    Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
    Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
    Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
    Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay.
    M'soka TJ; Nishioka J; Taga A; Kato K; Kawasaki H; Yamada Y; Yu A; Komada Y; Nobori T
    Leukemia; 2000 May; 14(5):935-40. PubMed ID: 10803528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia.
    Hori Y; Hori H; Yamada Y; Carrera CJ; Tomonaga M; Kamihira S; Carson DA; Nobori T
    Int J Cancer; 1998 Jan; 75(1):51-6. PubMed ID: 9426690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
    Nobori T; Takabayashi K; Tran P; Orvis L; Batova A; Yu AL; Carson DA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6203-8. PubMed ID: 8650244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
    Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.
    Zhang H; Chen ZH; Savarese TM
    Cancer Genet Cytogenet; 1996 Jan; 86(1):22-8. PubMed ID: 8616780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.
    Karikari CA; Mullendore M; Eshleman JR; Argani P; Leoni LM; Chattopadhyay S; Hidalgo M; Maitra A
    Mol Cancer Ther; 2005 Dec; 4(12):1860-6. PubMed ID: 16373701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
    Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
    Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
    Gordon RB; Blackwell K; Emmerson BT
    Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.